BUTYL-3-((DIMETHYLAMINO)METHYL)-4-HYDROXYBENZOATE

Suppliers

Names

[ CAS No. ]:
6279-54-5

[ Name ]:
BUTYL-3-((DIMETHYLAMINO)METHYL)-4-HYDROXYBENZOATE

[Synonym ]:
Butyl 3-((dimethylamino)methyl)-4-hydroxybenzoate
BENZOIC ACID,3-((DIMETHYLAMINO)METHYL)-4-HYDROXY,BUTYL ESTER

Chemical & Physical Properties

[ Density]:
1.083g/cm3

[ Boiling Point ]:
359.3ºC at 760 mmHg

[ Molecular Formula ]:
C14H21NO3

[ Molecular Weight ]:
251.32100

[ Flash Point ]:
171.1ºC

[ Exact Mass ]:
251.15200

[ PSA ]:
49.77000

[ LogP ]:
2.41070

[ Index of Refraction ]:
1.53

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DG8956000
CHEMICAL NAME :
Benzoic acid, 3-((dimethylamino)methyl)-4-hydroxy, butyl ester
CAS REGISTRY NUMBER :
6279-54-5
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C14-H21-N-O3
MOLECULAR WEIGHT :
251.36
WISWESSER LINE NOTATION :
4OVR DQ C1N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 11,85,1961
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
475 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 11,85,1961

Related Compounds

  • butyl 3-methyl-4-phenylthiopent-2-enoate
  • butyl 3-methyl-4-phenylsulfanylpent-2-enoate
  • 5-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]sulfonylthiophene-2-sulfonamide,hydrochloride
  • 1-[3-[(dimethylamino)methyl]-4-propoxyphenyl]-N,N-dimethylmethanamine
  • tert-butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylate
  • tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
  • N-[3-(Aminooxy)propyl]-N-butyl-1-butanamine